Abstract:Background: Hemophilia is a bleeding illness characterised by insufficient clotting factors, which may cause significant knee joint injury. Total Knee Joint Replacement (TKJR) has proposed as a promising therapy choice for Hemophilia patients with significant knee joint degeneration, with the goals of restoring joint function and reducing discomfort. Objectives: This study investigates the importance of TKJR in Hemophilia patients, focusing on preoperative concerns, surgical techniques, postoperative treatment, results, and problems exclusive to this community. Conclusions: TKJR has shown to be an effective therapeutic choice for people with significant knee joint degeneration due to haemophilia. Through a multidisciplinary approach, involving hematologists, orthopedic surgeons, and anesthesiologists, along with personalized care and thorough preoperative evaluation, successful outcomes can be achieved. Intraoperative clotting factor replacement therapy plays a crucial role in maintaining hemostasis during surgery. Postoperative management, including pain management, wound healing, and rehabilitation, contributes to functional recovery and improved quality of life. Although Hemophilia-specific complications exist, ongoing research, advancements in surgical techniques, implant materials, and gene therapy hold promise for further enhancing outcomes. Patient education, self-care, and adherence to prophylactic treatment are paramount in achieving long-term success. Continued collaboration and research efforts are necessary to optimize outcomes and improve the lives of Hemophilia patients undergoing TKJR. Background: Hemophilia is a bleeding illness characterised by insufficient clotting factors, which may cause significant knee joint injury. Total Knee Joint Replacement (TKJR) has proposed as a promising therapy choice for Hemophilia patients with significant knee joint degeneration, with the goals of restoring joint function and reducing discomfort. Objectives: This study investigates the importance of TKJR in Hemophilia patients, focusing on preoperative concerns, surgical techniques, postoperative treatment, results, and problems exclusive to this community. Conclusions: TKJR has shown to be an effective therapeutic choice for people with significant knee joint degeneration due to haemophilia. Through a multidisciplinary approach, involving hematologists, orthopedic surgeons, and anesthesiologists, along with personalized care and thorough preoperative evaluation, successful outcomes can be achieved. Intraoperative clotting factor replacement therapy plays a crucial role in maintaining hemostasis during surgery. Postoperative management, including pain management, wound healing, and rehabilitation, contributes to functional recovery and improved quality of life. Although Hemophilia-specific complications exist, ongoing research, advancements in surgical techniques, implant materials, and gene therapy hold promise for further enhancing outcomes. Patient education, self-care, and adherence to prophylactic treatment are paramount in achieving long-term success. Continued collaboration and research efforts are necessary to optimize outcomes and improve the lives of Hemophilia patients undergoing TKJR.

Optimizing long-term joint health in the treatment of hemophilia

Quality of Life in Haemophilia A: Hemophilia Utilization Group Study Va (Hugs-Va)

Efficacy of rehabilitation interventions on functioning in patients with hemophilic arthropathy: A systematic review with meta-analysis

Haemophilic arthropathy: Diagnosis, management, and aging patient considerations

Managing Surgical Risks in Hemophilic Elbow Arthropathy: An In-Depth Case Study and Literature Review

The Evolution of Hemophilia Pharmacological Treatments and Therapeutic Targets at the Turn of the Third Millennium

Hemophilia management: optimizing treatment based on patient needs

Assessing joint health in haemophilia patients: The combined value of physical examination and ultrasound imaging

Orthopedic surgery in hemophilic patients with musculoskeletal disorders: A systematic review

Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: A modified Delphi panel

Musculoskeletal ultrasound in hemophilia: Results and recommendations from a global survey and consensus meeting

Integrating musculoskeletal ultrasound as a shared decision-making tool in hemophilia care: observations from a 3-year study

The hemophilias and their clinical management: reports in the 55th ASH annual meeting

The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges

Shifting Paradigms and Arising Concerns in Severe Hemophilia A Treatment

Defining success in haemophilia care – Are we doing it right?

Anesthetic considerations for joint replacement surgery in hemophilic arthropathy: a comprehensive review

Haemophilia and Joint Disease: Pathophysiology, Evaluation, and Management

Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions

Management of Hemophilia in Older Patients

Total Knee Joint Replacement in Hemophilia Patient: A Comprehensive Review